BPC-157 with KPV dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
BPC-157 with KPV is two peptides sold together for gut problems, most often 10 mg of each in a 20 mg vial. Nobody has ever studied the pair. BPC-157 has five small studies in people, none given the way people use it. KPV has no data in people at all. And the vial is injected, while the claim is about the gut.
Evidence grade for BPC-157 with KPV: Animal or lab only. The rule: only animal or lab studies on this page. No study in people yet. The sum on this page: 1 animal study, no human study. A grade counts how much has been done to people, not whether it works.
- People given it
- 0
- Human studies
- 0
- Found nothing
- 0
Dose
No human dose established
No published study on this page has given this compound to people and reported a result.
1 animal study, no human study
7 effects reported, 4 unwanted, 3 wanted, by people using it, not a trial
Goal pages: Fat loss and metabolism
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
This is two peptides in one vial, sold for gut trouble. The usual vial is 10 mg of each. BPC-157 came out of stomach juice research. KPV is a three amino acid piece of a hormone that calms inflammation. On paper it is the most sensible blend on the market. No one has ever tested it.
What people take it for
- Bloating, loose stools and reflux.
- So called leaky gut.
- Calming an inflamed bowel.
- Healing an injury at the same time.
What studies in people showed
There is no trial of the pair. KPV has no human data at all. Not thin data. None. There is no registered study of it in people anywhere. What exists is two mouse gut studies, cell dishes, and a review that calls peptides like it future candidates. BPC-157 is barely better. The FDA counted five human studies with fewer than 110 people between them. Two were meeting abstracts. None ran past two weeks. None used a shot under the skin. Here is the part that gets missed. Both parts did their best work where the peptide touches gut tissue. The mouse KPV work was in the bowel. Much of the BPC-157 gut work went straight into the stomach. This product is sold to shoot under the skin. Nobody has compared the two routes in a person. Now the math. Mix 20 mg with 2 mL of water. Every unit mark carries 50 micrograms of each. A 5 unit draw is 250 micrograms of each. Some sellers use 5 mg and 5 mg, which halves all of that.
What people report
Reports, not study results
The good
- Bloating and loose stools settling in the first two weeks.
- Less reflux. This is the most common single report.
- Joint and tendon pain easing as a bonus.
The bad
- Nothing at all is common.
- Symptoms come back when you stop. People read that as proof it worked. It is also just what an ongoing gut problem does.
- You cannot turn one part down or stop one part.
- You cannot tell which of the two did anything, because you took both.
Where these come from: Peptide and bowel disease forums, clinic write-ups and seller pages. Gut symptoms move around on their own and respond hard to what people expect. Most of these people changed their diet at the same time.
My bottom line
The idea is good and the evidence is not there. One half has never been given to a human being in a study. I would not pay peptide prices for that.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
What people using it report
Real people telling you what happened to them. Nobody checked it, and the people who post are not a fair sample, so it cannot prove anything works. It is still the best guide on this page to what people actually do with BPC-157 with KPV, what they expect, and what goes wrong. The full account, including the negative reports, is below.
Animal and lab work, not yet tested in people
Real results, but from animals or cells, not people. What works in a mouse often does not work the same way in a person. Nobody can patent this, so nobody would ever earn back the cost of a study in people. That is usually why there is none. The record on this one is set out below.
- Losing weight1 animal or lab study
34 of the 36 indexed goals have no study of any kind behind BPC-157 with KPV
No study in people, animals or cells on this page reports a result for these. That does not prove BPC-157 with KPV does nothing for them. It does mean anything you have heard about BPC-157 with KPV and one of these did not come from a study cited here.
Show full evidence
What is BPC-157 with KPV?
BPC-157 with KPV is two peptides sold together for gut problems, most often 10 mg of each in a 20 mg vial. Nobody has ever studied the pair. BPC-157 has five small studies in people, none given the way people use it. KPV has no data in people at all. And the vial is injected, while the claim is about the gut.
On paper this blend makes sense, and that is why it is worth a careful look. BPC-157 came out of research on stomach juice, and most of its animal work is about the gut. KPV is the swelling-calming tail of a skin hormone, and its best animal work is in mice with an inflamed colon. Two gut peptides in one vial looks like a planned product, not a random bundle.
The math is easy because the split is usually even. Ten milligrams of each gives 20 mg of powder. Add 2 mL of water and each mL holds 10 mg in all, or 5 mg of each. One mark on a 100 unit insulin syringe gives 50 micrograms of BPC-157 and 50 micrograms of KPV. A 5 unit draw is 250 micrograms of each. Some sellers sell 5 plus 5, which cuts everything in half. So the milligrams on the label decide the math, not the name.
Now the part the product page leaves out. KPV has no data in people. Not thin data. None. There is no listed trial of KPV in people. The published work is mice with gut disease, cells in a dish, and tests of tiny delivery particles. For BPC-157, FDA staff counted the studies in people in 2026. They found five, with fewer than 110 people in all. Two were only conference summaries. None lasted more than two weeks. None gave it as a shot under the skin. So neither half of this vial has ever been injected into people in a study.
There is a second, quieter mismatch. Both peptides have their best results when they touch gut tissue directly. The KPV mouse work is in the gut. Much of the BPC-157 gut work gave it by mouth or straight into the stomach. This blend is sold as a shot under the skin. That is a very different way in, and no study has compared the two in a person.
How does BPC-157 with KPV work?
In gut and immune cells, KPV turns down swelling signals. That is the idea behind its results in mice. BPC-157 seems to help blood vessels grow and protect cells, as its own page explains. In rats and mice it protects the gut. No paper says what the two do together. Both work on swelling signals, so there is no reason to think their effects add up rather than overlap.
What have studies in people found about BPC-157 with KPV?
None for the pair. One of the two has no data in people at all, which is unusual even for a blend.
- BPC-157: FDA counted five studies in people, with fewer than 110 people in all. Two were only conference summaries. None gave it for more than two weeks, and none gave it as a shot under the skin.
- A 2025 review of BPC-157 in sports medicine kept 36 studies. 35 were in animals or in a dish. The one study in people looked back at 12 knee patients. 7 of the 12 said the pain eased for more than six months.
- KPV: no listed studies in people. The record is two kinds of gut disease in mice, cells in a dish, and a skin doctors' review that calls these peptides possible future treatments.
- The pair: no published study in people or animals, and no listed trial.
What this does not tell you: Neither peptide has been given to people in a proper study the way this product is used, for what it is sold for. So there is nothing in people for the blend as a whole, or for either half.
What do people who took BPC-157 with KPV report?
This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.
- Bloating and loose stools settling down in the first two weeks.
- Less reflux. This comes up more than any other single effect.
- Joint and tendon pain getting better as a bonus, which people credit to the BPC-157.
- Nothing at all, which is common.
- Problems coming back after stopping. People read this as proof it worked. It fits just as well with the problem simply carrying on.
Sources: Peptide and inflammatory bowel forums, clinic write-ups and vendor testimonial pages. Uncontrolled, usually alongside diet changes and other supplements. Reports, not evidence.
The state of the research
The story of how this blend should work is better than most. That is exactly the trap. A good story is not proof. This field is full of good stories that fell apart when someone finally ran the test. Two gut peptides that both calm swelling may add nothing to each other, and nobody has checked.
Gut problems also make reports hard to trust. They come and go. They change when people change their diet at the same time. And they respond strongly to what people expect. So a story of a gut blend working counts for less than the same story about something you can measure. That is why the forums on this product are very positive and not very useful.
The evidence, in charts
Fig. 1a · how many people
0people have taken this in any study cited here
0 people · 0 studies in people
What this page cites instead is 1 animal study and 3 reviews. None of them gave the compound to a person.
Counted from the list of sources on this page. We draw this chart only when a study in people is cited. An empty one is the answer, not a gap in the page.
Fig. 1b · evidence mix
None of the 4 sources here are studies in people.
- Animal study · done in animals125%
- Review of studies · sums up other studies375%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 4 different years, 2008 to 2026, counted from the list of sources on this page.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Blend
- Molecule weight
- A mixture. BPC-157 is about 1,419 Da and KPV about 342 Da, so the smaller peptide is a much larger share of the molecules than of the milligrams.
- Half-life
- Stated in words, not a numbersee the exact wording below
- Chain length
- None on file
Half-life as stated on file: Not defined for the blend, and no pharmacokinetic study of the mixture exists. The components clear at different rates and no figure has ever been published for KPV in people.
No amino acid sequence is on file for BPC-157 with KPV, which is expected: a blend is not built from amino acids.
Fig. 6 · what is in the vial
50%of a 20 mg BPC-157 with KPV vial is BPC-157
What the label says is in a standard vial. It is not a dose, and not a lab test. The seller fixes the mix, so when you draw the amount you want of one ingredient, you get a set amount of every other one with it. No study has tested this mix in people or animals.
The studies we cite
- Review of studies2019Are melanocortin peptides future therapeutics for cutaneous wound healing?
This is a skin doctors' review, not a test. It says KPV is a small piece of a skin hormone that keeps the calming effect but does not tan the skin. It suggests peptides like this could one day help wounds heal. The work it covers is computer models, cells in a dish, skin samples and animals. None of it is in people.
A dermatology review describing KPV as a truncated alpha-MSH peptide that keeps the anti-inflammatory activity without the pigment-inducing activity, and proposing peptides of this class as future candidates for cutaneous wounds. The experimental approaches it surveys are in silico, in vitro, ex vivo and animal.
- Review of studies2026FDA briefing document on BPC-157 for the July 2026 PCAC meeting
FDA staff counted every study of BPC-157 in people. They found five, with fewer than 110 people in all. Two were only short conference summaries. None gave it for longer than two weeks. None gave it as a shot under the skin, which is how people use it. Staff found no good human data, and they found products on the market with the wrong label.
FDA staff counted five published human studies of BPC-157 totalling fewer than 110 subjects, two of them meeting abstracts only, none dosing longer than two weeks, and none giving the peptide by subcutaneous injection. Staff found no adequate human data and mislabelled products in the market.
- Review of studies2025Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
This review looked hard for BPC-157 studies and found almost none in people. Out of 36 studies it kept, 35 were in animals or in a dish. The one study in people looked back at 12 patients with knee pain who had the peptide put into the knee. 7 of the 12 said the pain eased for more than six months. There was no comparison group. The review says the peptide lasts under 30 minutes in the body.
544 articles screened, 36 included, of which 35 were preclinical and one was clinical. That single clinical study was a retrospective series in which 7 of 12 patients reported relief beyond six months after intra-articular BPC-157 for unspecified chronic knee pain. The review puts the half-life at under 30 minutes.
- Animal study2008Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
In mice with an inflamed colon, KPV helped. The mice got better sooner and gained back more weight. Their colon tissue showed less swelling. This was two kinds of mouse gut disease, with KPV given on its own. It says nothing about people or about a blend.
In two mouse colitis models KPV produced earlier recovery, greater body-weight regain, fewer inflammatory infiltrates and lower myeloperoxidase activity in colon tissue. Mice, KPV given alone, nothing here about a blend or about people.
Where to buy BPC-157 with KPV
5 sellers list BPC-157 with KPV in our latest read. They are ranked by trust score, then by archive rating, then by certificate tier, then by the lowest price per milligram. Archive evidence is counted before source-backed. Each path is out of 4, and the two are not added. A higher price does not raise the score. The letter is the certificate chip. 1 of them has a published certificate that names BPC-157 with KPV.
Some seller links may pay this site when you buy through them. A payment never changes a seller's tier or rank, and no seller has a say in any page.
| Seller | Trust score | Vial sizes | From, per mg | Certificate for BPC-157 with KPV | Seller link |
|---|---|---|---|---|---|
| Reta One Labs | 49 WeakSource-backed 3 of 4. Archive evidence 3 of 4.A | 30 mg, 80 mg | $0.988 | Certificate, Kovera Labs | View |
| Liberty Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 30 mg | $8.17 | None found for BPC-157 with KPV | View |
| Cenexa Labs | 49 WeakSource-backed 2 of 4. Archive evidence 2 of 4.B | 20 mg | $6.00 | None found for BPC-157 with KPV | View |
| Sigma Compounds | 49 WeakSource-backed 3 of 4. Archive evidence 1 of 4.B | 2 mg | $78.5 | None found for BPC-157 with KPV | View |
| Life Link Research | 39 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 50 mg | $3.00 | None found for BPC-157 with KPV | View |
- LC Lab-confirmed: the issuing laboratory echoed this certificate back
- A Current certificate, independent laboratory named, laboratory not yet checked
- B Certificate published, but no laboratory link, older than a year, or the laboratory did not recognise the published lookup
- C No certificate could be read
Every listing and vial size for BPC-157 with KPV · How the trust score is counted
Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Common questions
Has BPC-157 with KPV been tested in people?
Not in any study cited here. BPC-157 with KPV is two peptides sold together for gut problems, most often 10 mg of each in a 20 mg vial. Nobody has ever studied the pair. BPC-157 has five small studies in people, none given the way people use it. KPV has no data in people at all. And the vial is injected, while the claim is about the gut.
What is the BPC-157 with KPV dosage?
No human dose established. No published study on this page has given this compound to people and reported a result. 1 animal study, no human study
Is BPC-157 with KPV FDA-approved?
Not approved, and never reviewed as a combination. FDA staff reviewed BPC-157 alone for the July 2026 meeting of the Pharmacy Compounding Advisory Committee, and found no adequate human data.
Does KPV have any human studies?
No. There is no listed trial of KPV in people and no published study in people. Everything is mice, cells, or review articles.
How much of each am I injecting?
Take the common 10 mg plus 10 mg vial mixed with 2 mL of water. Each unit mark on an insulin syringe holds 50 micrograms of each peptide. So a 5 unit draw is 250 micrograms of each. A 5 plus 5 vial gives half that.
Should I be taking this orally instead?
The gut results for both peptides came from putting them right where the gut is. The BPC-157 rat work put it straight into the stomach. The KPV mouse work was in the gut. This product is sold as a shot. Nobody has compared the two ways in a person. The honest answer is that the way with the evidence is not the way being sold.
Is this the same as KLOW without the copper and the TB-500?
Close. KLOW is these two plus TB-500 and a big dose of copper peptide. Cutting down to two removes the copper question. It leaves the two ingredients that are both aimed at the same target.
Can I lower one and keep the other?
Not from this vial. The mix is fixed and the plunger moves both. If you want to know which one is doing something, two separate vials is the only way to find out.